Providing systematic guidance in pharmacoeconomic guidelines for analysing costs

被引：0

作者：

Philip Jacobs

Arto Ohinmaa

Bruce Brady

机构：

[1] Institute of Health Economics,

[2] Canadian Coordinating Office for Health Technology Assessment,undefined

来源：

PharmacoEconomics | 2005年 / 23卷

关键词：

Average Cost; Excess Profit; Resource Identification; Resource Measurement; Methodological Uncertainty;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Background: Despite the considerable amount of work that has gone into the standardisation of costs, a recent survey indicated that there is still a wide variation in methods used in costing studies in the published literature. Part of the answer to the lack of standardisation may lie in pharmacoeconomic guidelines themselves.

引用

页码：143 / 153

页数：10

共 50 条

[1] Providing systematic guidance in pharmacoeconomic guidelines for analysing costs
Jacobs, P
Ohinmaa, A
Brady, B
PHARMACOECONOMICS, 2005, 23 (02) : 143 - 153
[2] A systematic review of pharmacoeconomic guidelines
Zhao, Ye
Feng, Hai-ming
Qu, Ji
Luo, Xiu
Ma, Wen-juan
Tian, Jin-hui
JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (01) : 85 - 96
[3] Analysing the Benefits and Costs of Bicycle Facilities via Online Guidelines
Krizek, Kevin
Poindexter, Gavin
Barnes, Gary
Mogush, Paul
PLANNING PRACTICE AND RESEARCH, 2007, 22 (02): : 197 - 213
[4] Polish guidelines for costing in pharmacoeconomic evaluation in comparison to existing guidance for costing in other countries
Orlewska, E
Mierzejewski, P
Cel, M
VALUE IN HEALTH, 2003, 6 (03) : 204 - 204
[5] GUIDELINES FOR PHARMACOECONOMIC STUDIES
MCGHAN, WF
LEWIS, NJW
CLINICAL THERAPEUTICS, 1992, 14 (03) : 486 - 494
[6] Guidelines for pharmacoeconomic research fellowships
Lee, J
Lawrence, BJ
Sullivan, SD
Johnson, NE
Barriere, SL
Lake, KD
Stevenson, JG
PHARMACOTHERAPY, 1999, 19 (09): : 1105 - 1109
[7] GUIDELINES FOR PERFORMING A PHARMACOECONOMIC ANALYSIS
JOLICOEUR, LM
JONESGRIZZLE, AJ
BOYER, JG
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1992, 49 (07): : 1741 - 1747
[8] A COMPARATIVE REVIEW OF PHARMACOECONOMIC GUIDELINES
JACOBS, P
BACHYNSKY, J
BALADI, JF
PHARMACOECONOMICS, 1995, 8 (03) : 182 - 189
[9] GUIDELINES FOR PHARMACOECONOMIC EVALUATION FOR SERBIA
Novakovic, T.
Tesic, D.
Stefanovic, D.
Medic, G.
Sovtic, D.
VALUE IN HEALTH, 2011, 14 (07) : A358 - A358
[10] Sampling Uncertainty in the Cost-Effectiveness Evaluations and Guidance Given by the Existing Pharmacoeconomic Guidelines: A Question to Be Considered
Carayanni, Vilelmine
DRUG INFORMATION JOURNAL, 2009, 43 (02): : 185 - 194

← 1 2 3 4 5 →